Multimedia Release

Kiora's investigational treatment for retinitis pigmentosa, KIO-301, demonstrates visual function restoration in patients who are blind

Meeting Announcement

Kiora Pharmaceuticals

Patient Interview Post Injection

video: Patient interview as part of the ABACUS study of KIO-301 for the treatment of retinitis pigmentosa. view more 

Credit: Kiora

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.